These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12832103)

  • 1. Intracerebral oxytocin modulates sleep-wake behaviour in male rats.
    Lancel M; Krömer S; Neumann ID
    Regul Pept; 2003 Jul; 114(2-3):145-52. PubMed ID: 12832103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain oxytocin inhibits the (re)activity of the hypothalamo-pituitary-adrenal axis in male rats: involvement of hypothalamic and limbic brain regions.
    Neumann ID; Krömer SA; Toschi N; Ebner K
    Regul Pept; 2000 Dec; 96(1-2):31-8. PubMed ID: 11102649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo-pituitary-adrenal axis in male and female rats: partial action within the paraventricular nucleus.
    Neumann ID; Wigger A; Torner L; Holsboer F; Landgraf R
    J Neuroendocrinol; 2000 Mar; 12(3):235-43. PubMed ID: 10718919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quiet wakefulness: the influence of intraperitoneal and intranasal oxytocin on sleep-wake behavior and neurophysiology in rats.
    Raymond JS; Everett NA; Gururajan A; Bowen MT
    Sleep; 2023 Jul; 46(7):. PubMed ID: 37039749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action.
    España RA; Baldo BA; Kelley AE; Berridge CW
    Neuroscience; 2001; 106(4):699-715. PubMed ID: 11682157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive effect of 5-HT2C and CB1 receptor blockade on the regulation of sleep-wake cycle.
    Bogáthy E; Papp N; Tóthfalusi L; Vas S; Bagdy G
    BMC Neurosci; 2019 Mar; 20(1):14. PubMed ID: 30894126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain oxytocin: differential inhibition of neuroendocrine stress responses and anxiety-related behaviour in virgin, pregnant and lactating rats.
    Neumann ID; Torner L; Wigger A
    Neuroscience; 2000; 95(2):567-75. PubMed ID: 10658637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats.
    Akanmu MA; Honda K
    Brain Res; 2005 Jun; 1048(1-2):138-45. PubMed ID: 15919057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat strains that differ in corticotropin-releasing hormone production exhibit different sleep-wake responses to interleukin 1.
    Opp MR; Imeri L
    Neuroendocrinology; 2001 Apr; 73(4):272-84. PubMed ID: 11340341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of central oxytocin in the inhibition by endotoxin of distension-stimulated gastric acid secretion.
    Calatayud S; Quintana E; Esplugues J; Barrachina MD
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):676-82. PubMed ID: 10619185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of intracerebroventricular application of 8-Br-cGMP and LY-83,583, a guanylyl cyclase inhibitor, on sleep-wake activity in rats.
    Ribeiro AC; Kapás L
    Brain Res; 2005 Jul; 1049(1):25-33. PubMed ID: 15922313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of CaMKII in the rat dorsal raphe nucleus plays an important role in sleep-wake regulation.
    Cui SY; Li SJ; Cui XY; Zhang XQ; Yu B; Sheng ZF; Huang YL; Cao Q; Xu YP; Lin ZG; Yang G; Song JZ; Ding H; Wang ZJ; Zhang YH
    J Neurochem; 2016 Feb; 136(3):609-19. PubMed ID: 26558357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
    Monti JM; Jantos H
    Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats.
    Piper DC; Upton N; Smith MI; Hunter AJ
    Eur J Neurosci; 2000 Feb; 12(2):726-30. PubMed ID: 10712652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obestatin alters sleep in rats.
    Szentirmai E; Krueger JM
    Neurosci Lett; 2006 Aug; 404(1-2):222-6. PubMed ID: 16806691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat.
    Murillo-Rodríguez E; Vázquez E; Millán-Aldaco D; Palomero-Rivero M; Drucker-Colin R
    Eur J Pharmacol; 2007 May; 562(1-2):82-91. PubMed ID: 17336288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin interactions with oxytocin in the control of female sexual behavior.
    Pedersen CA; Boccia ML
    Neuroscience; 2006; 139(3):843-51. PubMed ID: 16488546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic icv infusion of vasopressin on sleep-waking cycle of rats.
    Arnauld E; Bibene V; Meynard J; Rodriguez F; Vincent JD
    Am J Physiol; 1989 Mar; 256(3 Pt 2):R674-84. PubMed ID: 2923256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective dopamine D4 receptor antagonist, L-741,741, on sleep and wakefulness in the rat.
    Cavas M; Navarro JF
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):668-78. PubMed ID: 16457926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.